![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
Rambam Health Care Campus |
---|---|
Information provided by: | Rambam Health Care Campus |
ClinicalTrials.gov Identifier: | NCT00230152 |
The synergistic value of the fusion of physiologic and anatomical data has been described using several co-registration techniques for various nuclear medicine procedures and morphologic imaging modalities (single photon emission computed tomography-computed tomography [SPECT-CT], SPECT-magnetic resonance imaging [MRI], camera-based positron emission tomography [PET]-CT and PET-CT). The researchers hypothesize that fusion of nuclear medicine (NM) and CT data acquired sequentially in a single imaging session on one device is clinically superior to side-by-side evaluation of separately performed imaging tests. They hypothesize that more accurate localization of increased radiotracer activity on NM procedures will improve the diagnostic accuracy for detection of infection and will subsequently have a significant impact on patient management.
The purpose of the present study is to assess the clinical value of this new technology of fused imaging in patients undergoing diagnostic nuclear medicine evaluation for suspicion of an infection process.
Condition | Intervention |
---|---|
Infectious Diseases |
Device: PET-CT imaging Device: SPECT-CT imaging |
Study Type: | Interventional |
Study Design: | Diagnostic, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment |
Official Title: | Nuclear Medicine for the Evaluation of Infection-the Added Value of Hybrid Imaging Modalities |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Zohar Kiedar, MD, PhD | 972-4-8543009 | zohar@keidar.net |
Contact: Rachel Bar-Shalom, MD | 972-4-8543009 | r_bar_shalom@rambam.health.gov.il |
Israel | |
Rambam Medical Center | Recruiting |
Haifa, Israel | |
Contact: Zohar Kiedar, MD, PhD 972-4-8543009 zohar@kiedar.net | |
Principal Investigator: Zohar Kiedar, MD, PhD | |
Sub-Investigator: Rachel Bar-Shalom, MD |
Principal Investigator: | Zohar Keidar, MD, PhD | Rambam Health Care Campus |
Study ID Numbers: | infectionCTIL |
Study First Received: | September 29, 2005 |
Last Updated: | February 13, 2006 |
ClinicalTrials.gov Identifier: | NCT00230152 |
Health Authority: | Israel: Israeli Health Ministry Pharmaceutical Administration |
Communicable Diseases Infection |